| class_id,class_name,number_annotated,source
|
| WP100,Glutathione metabolism,19,wikipathways
|
| WP106,Alanine and aspartate metabolism,12,wikipathways
|
| WP107,Translation factors,52,wikipathways
|
| WP111,Electron transport chain OXPHOS system in mitochondria,105,wikipathways
|
| WP117,GPCRs other,96,wikipathways
|
| WP12,Osteoclast signaling,16,wikipathways
|
| WP127,IL5 signaling,37,wikipathways
|
| WP129,Matrix metalloproteinases,30,wikipathways
|
| WP138,Androgen receptor signaling,87,wikipathways
|
| WP1403,AMP activated protein kinase signaling,67,wikipathways
|
| WP1422,Sphingolipid pathway,30,wikipathways
|
| WP1423,Ganglio sphingolipid metabolism,13,wikipathways
|
| WP1425,Bone morphogenic protein signaling and regulation,12,wikipathways
|
| WP143,Fatty acid beta oxidation,34,wikipathways
|
| WP1433,Nucleotide binding oligomerization domain NOD pathway,41,wikipathways
|
| WP1434,Osteopontin signaling,13,wikipathways
|
| WP1449,Regulation of toll like receptor signaling,145,wikipathways
|
| WP1455,Serotonin transporter activity,11,wikipathways
|
| WP1471,Target of rapamycin signaling,36,wikipathways
|
| WP15,Selenium micronutrient network,87,wikipathways
|
| WP1528,Physiological and pathological hypertrophy of the heart,24,wikipathways
|
| WP1530,miRNA regulation of DNA damage response,73,wikipathways
|
| WP1531,Vitamin D metabolism,10,wikipathways
|
| WP1533,Vitamin B12 metabolism,55,wikipathways
|
| WP1539,Angiogenesis,24,wikipathways
|
| WP1541,Energy metabolism,48,wikipathways
|
| WP1544,MicroRNAs in cardiomyocyte hypertrophy,104,wikipathways
|
| WP1545,miRNAs involved in DNA damage response,68,wikipathways
|
| WP1584,Type II diabetes mellitus,21,wikipathways
|
| WP1589,Folate alcohol and cancer pathway hypotheses,10,wikipathways
|
| WP1591,Heart development,47,wikipathways
|
| WP1601,Fluoropyrimidine activity,34,wikipathways
|
| WP1602,Nicotine effect on dopaminergic neurons,21,wikipathways
|
| WP1604,Codeine and morphine metabolism,15,wikipathways
|
| WP167,Eicosanoid synthesis,23,wikipathways
|
| WP170,Nuclear receptors,38,wikipathways
|
| WP1742,TP53 network,19,wikipathways
|
| WP176,Folate metabolism,70,wikipathways
|
| WP1772,Apoptosis modulation and signaling,92,wikipathways
|
| WP179,Cell cycle,120,wikipathways
|
| WP183,Proteasome degradation,62,wikipathways
|
| WP185,Integrin mediated cell adhesion,102,wikipathways
|
| WP186,Homologous recombination,13,wikipathways
|
| WP1946,Cori cycle,17,wikipathways
|
| WP195,IL1 signaling,54,wikipathways
|
| WP197,Cholesterol biosynthesis pathway,15,wikipathways
|
| WP1971,Integrated cancer pathway,45,wikipathways
|
| WP1981,Thyroxine thyroid hormone production,26,wikipathways
|
| WP1982,Sterol regulatory element binding proteins SREBP signaling,69,wikipathways
|
| WP1984,Integrated breast cancer pathway,154,wikipathways
|
| WP1991,SRF and miRs in smooth muscle differentiation and proliferation,12,wikipathways
|
| WP1992,Genes targeted by miRNAs in adipocytes,13,wikipathways
|
| WP1993,Angiogenesis overview,64,wikipathways
|
| WP1995,Effects of nitric oxide,10,wikipathways
|
| WP2001,miR targeted genes in adipocytes,19,wikipathways
|
| WP2003,miR targeted genes in leukocytes,127,wikipathways
|
| WP2004,miR targeted genes in lymphocytes,424,wikipathways
|
| WP2005,miR targeted genes in muscle cell,353,wikipathways
|
| WP2006,miR targeted genes in squamous cell,129,wikipathways
|
| WP2007,Iron metabolism in placenta,11,wikipathways
|
| WP2011,SREBF and miR33 in cholesterol and lipid homeostasis,16,wikipathways
|
| WP2018,RANKL RANK signaling,50,wikipathways
|
| WP2023,Cell differentiation expanded index,59,wikipathways
|
| WP2029,Cell differentiation index,21,wikipathways
|
| WP2032,Thyroid stimulating hormone TSH signaling,58,wikipathways
|
| WP2034,Leptin signaling,71,wikipathways
|
| WP2035,Follicle stimulating hormone FSH signaling,24,wikipathways
|
| WP2036,TNF related weak inducer of apoptosis TWEAK signaling,38,wikipathways
|
| WP2037,Prolactin signaling,74,wikipathways
|
| WP2038,Microtubule cytoskeleton regulation,48,wikipathways
|
| WP205,IL7 signaling,20,wikipathways
|
| WP2059,Alzheimer 39 s disease and miRNA effects,269,wikipathways
|
| WP206,Fatty acid omega oxidation,15,wikipathways
|
| WP2064,Neural crest differentiation,101,wikipathways
|
| WP2112,IL17 signaling,32,wikipathways
|
| WP2113,Type III interferon signaling,10,wikipathways
|
| WP2118,Arrhythmogenic right ventricular cardiomyopathy,75,wikipathways
|
| WP2197,Endothelin pathways,32,wikipathways
|
| WP22,IL9 signaling,17,wikipathways
|
| WP2203,Thymic stromal lymphopoietin TSLP signaling,37,wikipathways
|
| WP2249,Metastatic brain tumor,13,wikipathways
|
| WP2261,Glioblastoma signaling,82,wikipathways
|
| WP2263,Androgen receptor network in prostate cancer,113,wikipathways
|
| WP2267,Synaptic vesicle pathway,51,wikipathways
|
| WP2272,Pathogenic Escherichia coli infection,55,wikipathways
|
| WP2289,Drug induction of bile acid pathway,17,wikipathways
|
| WP229,Irinotecan pathway,12,wikipathways
|
| WP2290,RalA downstream regulated genes,12,wikipathways
|
| WP2291,Deregulation of Rab and Rab effector genes in bladder cancer,16,wikipathways
|
| WP23,B cell receptor signaling,92,wikipathways
|
| WP231,TNF alpha signaling,89,wikipathways
|
| WP2324,AGE RAGE pathway,66,wikipathways
|
| WP2328,Allograft rejection,90,wikipathways
|
| WP2332,IL11 signaling,44,wikipathways
|
| WP2333,Trans sulfuration pathway,11,wikipathways
|
| WP2355,Corticotropin releasing hormone signaling,93,wikipathways
|
| WP2359,Parkin ubiquitin proteasomal system pathway,71,wikipathways
|
| WP236,Adipogenesis,131,wikipathways
|
| WP2361,Gastric cancer network 1,28,wikipathways
|
| WP2363,Gastric cancer network 2,31,wikipathways
|
| WP2369,Histone modifications,65,wikipathways
|
| WP2371,Parkinson 39 s disease pathway,38,wikipathways
|
| WP2374,Oncostatin M signaling,56,wikipathways
|
| WP2380,Brain derived neurotrophic factor BDNF signaling,137,wikipathways
|
| WP24,Peptide GPCRs,75,wikipathways
|
| WP2406,Cardiac progenitor differentiation,53,wikipathways
|
| WP241,One carbon metabolism,29,wikipathways
|
| WP2431,Spinal cord injury,120,wikipathways
|
| WP2435,Quercetin and Nf kB AP 1 induced apoptosis,16,wikipathways
|
| WP2436,Dopamine metabolism,13,wikipathways
|
| WP244,Alpha 6 beta 4 signaling,33,wikipathways
|
| WP2446,Retinoblastoma gene in cancer,89,wikipathways
|
| WP2447,Amyotrophic lateral sclerosis ALS ,39,wikipathways
|
| WP2453,TCA cycle and deficiency of pyruvate dehydrogenase complex PDHc ,16,wikipathways
|
| WP247,Small ligand GPCRs,19,wikipathways
|
| WP2507,Nanomaterial induced apoptosis,20,wikipathways
|
| WP2509,Nanoparticle triggered autophagic cell death,23,wikipathways
|
| WP2513,Nanoparticle triggered regulated necrosis,12,wikipathways
|
| WP2516,ATM signaling,37,wikipathways
|
| WP2525,Trans sulfuration one carbon metabolism and related pathways,69,wikipathways
|
| WP2526,PDGF pathway,40,wikipathways
|
| WP2533,Glycerophospholipid biosynthetic pathway,31,wikipathways
|
| WP254,Apoptosis,88,wikipathways
|
| WP2571,Polycystic kidney disease pathway,85,wikipathways
|
| WP2572,Primary focal segmental glomerulosclerosis FSGS ,72,wikipathways
|
| WP2583,T cell receptor and co stimulatory signaling,28,wikipathways
|
| WP2586,Aryl hydrocarbon receptor response to main mediators PAH and TCDD,46,wikipathways
|
| WP2596,Gastric acid production,13,wikipathways
|
| WP26,S1P receptor signal transduction,25,wikipathways
|
| WP262,Ebstein Barr virus LMP1 signaling,23,wikipathways
|
| WP2636,Common pathways underlying drug addiction,41,wikipathways
|
| WP2637,Interleukin 1 IL 1 structural pathway,49,wikipathways
|
| WP2643,Nanoparticle mediated activation of receptor signaling,28,wikipathways
|
| WP268,Notch signaling,45,wikipathways
|
| WP272,Blood clotting cascade,22,wikipathways
|
| WP2795,Cardiac hypertrophic response,54,wikipathways
|
| WP28,Selenium metabolism and selenoproteins,47,wikipathways
|
| WP2806,Complement system,95,wikipathways
|
| WP2813,Mammary gland development embryonic development stage 1 of 4,18,wikipathways
|
| WP2814,Mammary gland development puberty stage 2 of 4,13,wikipathways
|
| WP2815,Mammary gland development involution stage 4 of 4,10,wikipathways
|
| WP2817,Mammary gland development pregnancy and lactation stage 3 of 4,46,wikipathways
|
| WP2828,Bladder cancer,40,wikipathways
|
| WP2839,Hair follicle development organogenesis stage 2 of 3,32,wikipathways
|
| WP2840,Hair follicle development cytodifferentiation stage 3 of 3,87,wikipathways
|
| WP2848,Pluripotent stem cell differentiation pathway,48,wikipathways
|
| WP2849,Hematopoietic stem cell differentiation,59,wikipathways
|
| WP2853,Endoderm differentiation,144,wikipathways
|
| WP2854,Gene regulatory network modeling somitogenesis ,11,wikipathways
|
| WP2855,Dopaminergic neurogenesis,30,wikipathways
|
| WP2857,Mesodermal commitment pathway,147,wikipathways
|
| WP2858,Ectoderm differentiation,141,wikipathways
|
| WP286,IL3 signaling,49,wikipathways
|
| WP2864,Apoptosis related network due to altered Notch3 in ovarian cancer,53,wikipathways
|
| WP2865,IL1 and megakaryocytes in obesity,24,wikipathways
|
| WP2870,Extracellular vesicle mediated signaling in recipient cells,29,wikipathways
|
| WP2873,Aryl hydrocarbon receptor pathway,45,wikipathways
|
| WP2874,Liver X receptor pathway,10,wikipathways
|
| WP2875,Constitutive androstane receptor pathway,31,wikipathways
|
| WP2876,Pregnane X receptor pathway,32,wikipathways
|
| WP2877,Vitamin D receptor pathway,187,wikipathways
|
| WP2878,PPAR alpha pathway,26,wikipathways
|
| WP2879,Farnesoid X receptor pathway,19,wikipathways
|
| WP2880,Glucocorticoid receptor pathway,70,wikipathways
|
| WP2881,Estrogen receptor pathway,13,wikipathways
|
| WP2882,Nuclear receptors meta pathway,314,wikipathways
|
| WP2884,NRF2 pathway,141,wikipathways
|
| WP289,Myometrial relaxation and contraction pathways,156,wikipathways
|
| WP2895,Differentiation of white and brown adipocyte,25,wikipathways
|
| WP2911,miRNA targets in ECM and membrane receptors,38,wikipathways
|
| WP2916,Interactome of polycomb repressive complex 2 PRC2 ,16,wikipathways
|
| WP299,Nuclear receptors in lipid metabolism and toxicity,35,wikipathways
|
| WP3,Transcriptional activation by NRF2 in response to phytochemicals,15,wikipathways
|
| WP304,Kit receptor signaling,53,wikipathways
|
| WP306,Focal adhesion,199,wikipathways
|
| WP313,Hepatocyte growth factor receptor signaling,35,wikipathways
|
| WP314,Fas ligand pathway and stress induction of heat shock proteins,43,wikipathways
|
| WP322,Osteoblast signaling,14,wikipathways
|
| WP325,Triacylglyceride synthesis,24,wikipathways
|
| WP3286,Copper homeostasis,51,wikipathways
|
| WP3287,Overview of nanoparticle effects,19,wikipathways
|
| WP3298,Melatonin metabolism and effects,35,wikipathways
|
| WP3299,let 7 inhibition of ES cell reprogramming,15,wikipathways
|
| WP3301,MFAP5 mediated ovarian cancer cell motility and invasiveness,13,wikipathways
|
| WP3303,RAC1 PAK1 p38 MMP2 pathway,68,wikipathways
|
| WP334,GPCRs class B secretin like,24,wikipathways
|
| WP3391,Senescence associated secretory phenotype SASP ,113,wikipathways
|
| WP34,Ovarian infertility,39,wikipathways
|
| WP3413,NOTCH1 regulation of endothelial cell calcification,17,wikipathways
|
| WP3414,Initiation of transcription and translation elongation at the HIV 1 LTR,32,wikipathways
|
| WP35,G protein signaling,91,wikipathways
|
| WP3527,Pre implantation embryo,58,wikipathways
|
| WP3529,Zinc homeostasis,36,wikipathways
|
| WP357,Fatty acid biosynthesis,22,wikipathways
|
| WP3580,Methionine de novo and salvage pathway,22,wikipathways
|
| WP3584,MECP2 and associated Rett syndrome,74,wikipathways
|
| WP3591,Sleep regulation,38,wikipathways
|
| WP3594,Circadian rhythm genes,201,wikipathways
|
| WP3599,Transcription factor regulation in adipogenesis,22,wikipathways
|
| WP3601,Lipid particles composition,10,wikipathways
|
| WP3611,Photodynamic therapy induced AP 1 survival signaling,51,wikipathways
|
| WP3612,Photodynamic therapy induced NFE2L2 NRF2 survival signaling,23,wikipathways
|
| WP3613,Photodynamic therapy induced unfolded protein response,27,wikipathways
|
| WP3614,Photodynamic therapy induced HIF 1 survival signaling,38,wikipathways
|
| WP3617,Photodynamic therapy induced NF kB survival signaling,35,wikipathways
|
| WP3624,Lung fibrosis,63,wikipathways
|
| WP363,Wnt signaling NetPath,47,wikipathways
|
| WP3630,NAD metabolism sirtuins and aging,11,wikipathways
|
| WP364,IL6 signaling,43,wikipathways
|
| WP3640,Imatinib and chronic myeloid leukemia,20,wikipathways
|
| WP3644,NAD metabolism,16,wikipathways
|
| WP3645,NAD biosynthetic pathways,22,wikipathways
|
| WP3646,Hepatitis C and hepatocellular carcinoma,56,wikipathways
|
| WP3651,Pathways affected in adenoid cystic carcinoma,65,wikipathways
|
| WP3656,Interleukin 1 induced activation of NF kB,10,wikipathways
|
| WP3657,Hematopoietic stem cell gene regulation by GABP alpha beta complex,21,wikipathways
|
| WP3658,Wnt beta catenin signaling in leukemia,26,wikipathways
|
| WP3664,Regulation of Wnt B catenin signaling by small molecule compounds,17,wikipathways
|
| WP3668,Hypothesized pathways in pathogenesis of cardiovascular disease,25,wikipathways
|
| WP3670,Interactions between LOXL4 and oxidative stress pathway,18,wikipathways
|
| WP3676,BDNF TrkB signaling,33,wikipathways
|
| WP3678,Amplification and expansion of oncogenic pathways as metastatic traits,17,wikipathways
|
| WP3679,Cell type dependent selectivity of CCK2R signaling,13,wikipathways
|
| WP368,Mitochondrial long chain fatty acid beta oxidation,17,wikipathways
|
| WP3680,Physico chemical features and toxicity associated pathways,66,wikipathways
|
| WP382,MAPK signaling,247,wikipathways
|
| WP383,Striated muscle contraction pathway,38,wikipathways
|
| WP384,Apoptosis modulation by HSP70,19,wikipathways
|
| WP3844,PI3K AKT mTOR signaling and therapeutic opportunities in prostate cancer,32,wikipathways
|
| WP3845,Canonical and non canonical Notch signaling,27,wikipathways
|
| WP3849,MAPK and NFkB signaling inhibited by Yersinia YopJ,12,wikipathways
|
| WP3850,Factors and pathways affecting insulin like growth factor IGF1 Akt signaling,36,wikipathways
|
| WP3851,TLR4 signaling and tolerance,28,wikipathways
|
| WP3853,ERK pathway in Huntington 39 s disease,17,wikipathways
|
| WP3858,Toll like receptor signaling related to MyD88,31,wikipathways
|
| WP3859,TGF beta signaling in thyroid cells for epithelial mesenchymal transition,19,wikipathways
|
| WP3863,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,62,wikipathways
|
| WP3865,Novel intracellular components of RIG I like receptor pathway,60,wikipathways
|
| WP3869,Cannabinoid receptor signaling,29,wikipathways
|
| WP3871,Valproic acid pathway,12,wikipathways
|
| WP3872,Apoptosis regulation by parathyroid hormone related protein,25,wikipathways
|
| WP3873,RIOK1 and RIOK2 in EGFR and PI3K mediated tumorigenesis,15,wikipathways
|
| WP3874,Canonical and non canonical TGF B signaling,17,wikipathways
|
| WP3875,ATR signaling,11,wikipathways
|
| WP3876,BMP2 WNT4 FOXO1 pathway in primary endometrial stromal cell differentiation,13,wikipathways
|
| WP3877,MYD88 distinct input output pathway,18,wikipathways
|
| WP3878,ATM signaling in development and disease ,47,wikipathways
|
| WP3879,4 hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression,25,wikipathways
|
| WP3888,VEGFA VEGFR2 signaling,432,wikipathways
|
| WP3892,Development of pulmonary dendritic cells and macrophage subsets,13,wikipathways
|
| WP3893,Development and heterogeneity of the ILC family,33,wikipathways
|
| WP3896,Dengue 2 interactions with complement and coagulation cascades,59,wikipathways
|
| WP391,Mitochondrial gene expression,19,wikipathways
|
| WP3915,Angiopoietin like protein 8 regulatory pathway,132,wikipathways
|
| WP3925,Amino acid metabolism,92,wikipathways
|
| WP3927,BMP signaling in eyelid development,20,wikipathways
|
| WP3929,Chemokine signaling,165,wikipathways
|
| WP3930,EDA signaling in hair follicle development,14,wikipathways
|
| WP3931,Embryonic stem cell pluripotency pathways,118,wikipathways
|
| WP3932,Focal adhesion PI3K Akt mTOR signaling,304,wikipathways
|
| WP3933,Kennedy pathway from sphingolipids,14,wikipathways
|
| WP3934,Leptin and adiponectin,10,wikipathways
|
| WP3935,Leptin insulin signaling overlap,17,wikipathways
|
| WP3937,Microglia pathogen phagocytosis pathway,40,wikipathways
|
| WP3941,Oxidative damage response,40,wikipathways
|
| WP3942,PPAR signaling,50,wikipathways
|
| WP3944,Serotonin and anxiety related events,14,wikipathways
|
| WP3945,TYROBP causal network in microglia,62,wikipathways
|
| WP3947,Serotonin and anxiety,18,wikipathways
|
| WP395,IL4 signaling,50,wikipathways
|
| WP3958,GPR40 role in insulin secretion,15,wikipathways
|
| WP3959,DNA IR double strand breaks and cellular response via ATM,55,wikipathways
|
| WP3965,Lipid metabolism pathway,29,wikipathways
|
| WP3967,miR 509 3p alteration of YAP1 ECM axis,18,wikipathways
|
| WP3969,H19 Rb E2F1 and CDK beta catenin in colorectal cancer,14,wikipathways
|
| WP3971,OSX and miRNAs in tooth development,34,wikipathways
|
| WP3972,PDGFR beta pathway,29,wikipathways
|
| WP3981,miRNA regulation of prostate cancer signaling,31,wikipathways
|
| WP3982,miRNA regulation of p53 pathway in prostate cancer,31,wikipathways
|
| WP399,Wnt signaling and pluripotency,102,wikipathways
|
| WP3995,Prion disease pathway,33,wikipathways
|
| WP3996,Ethanol effects on histone modifications,31,wikipathways
|
| WP3998,Prader Willi and Angelman syndrome,110,wikipathways
|
| WP400,p38 MAPK signaling,35,wikipathways
|
| WP4008,NO cGMP PKG mediated neuroprotection,46,wikipathways
|
| WP4016,DNA IR damage and cellular response via ATR,82,wikipathways
|
| WP4018,Clear cell renal cell carcinoma pathways,83,wikipathways
|
| WP4022,Pyrimidine metabolism,84,wikipathways
|
| WP404,Nucleotide metabolism,19,wikipathways
|
| WP405,Eukaryotic transcription initiation,42,wikipathways
|
| WP408,Oxidative stress response,33,wikipathways
|
| WP410,Exercise induced circadian regulation,48,wikipathways
|
| WP411,mRNA processing,135,wikipathways
|
| WP4136,Fibrin complement receptor 3 signaling,44,wikipathways
|
| WP4141,PI3K AKT mTOR vitamin D3 signaling,22,wikipathways
|
| WP4142,Metabolism of sphingolipids in ER and Golgi apparatus,21,wikipathways
|
| WP4147,PTF1A related regulatory pathway,11,wikipathways
|
| WP4148,Splicing factor NOVA regulated synaptic proteins,42,wikipathways
|
| WP4149,White fat cell differentiation,32,wikipathways
|
| WP4150,Wnt signaling in kidney disease,38,wikipathways
|
| WP4153,Degradation pathway of sphingolipids including diseases,17,wikipathways
|
| WP4155,Endometrial cancer,63,wikipathways
|
| WP4156,Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine,15,wikipathways
|
| WP4157,GABA metabolism aka GHB ,11,wikipathways
|
| WP4159,GABA receptor signaling,31,wikipathways
|
| WP4172,PI3K Akt signaling,340,wikipathways
|
| WP4190,Mevalonate arm of cholesterol biosynthesis pathway,13,wikipathways
|
| WP4197,Interferon signaling in tuberculosis,23,wikipathways
|
| WP4204,Tumor suppressor activity of SMARCB1,31,wikipathways
|
| WP4205,MET in type 1 papillary renal cell carcinoma,61,wikipathways
|
| WP4206,Hereditary leiomyomatosis and renal cell carcinoma pathway,20,wikipathways
|
| WP4210,Tryptophan catabolism leading to NAD production,16,wikipathways
|
| WP4211,Transcriptional cascade regulating adipogenesis,13,wikipathways
|
| WP4216,Chromosomal and microsatellite instability in colorectal cancer ,73,wikipathways
|
| WP4217,Ebola virus infection in host,129,wikipathways
|
| WP422,MAPK cascade,33,wikipathways
|
| WP4220,Neurotransmitter disorders,10,wikipathways
|
| WP4222,Phosphodiesterases in neuronal function,56,wikipathways
|
| WP4223,Ras signaling,185,wikipathways
|
| WP4224,Purine metabolism and related disorders,23,wikipathways
|
| WP4225,Pyrimidine metabolism and related diseases,20,wikipathways
|
| WP4236,Krebs cycle disorders,13,wikipathways
|
| WP4239,Epithelial to mesenchymal transition in colorectal cancer,162,wikipathways
|
| WP4240,Regulation of sister chromatid separation at the metaphase anaphase transition,14,wikipathways
|
| WP4241,Type 2 papillary renal cell carcinoma,34,wikipathways
|
| WP4249,Hedgehog signaling,43,wikipathways
|
| WP4255,Non small cell lung cancer,75,wikipathways
|
| WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,98,wikipathways
|
| WP4259,Disorders of folate metabolism and transport,19,wikipathways
|
| WP4262,Breast cancer pathway,155,wikipathways
|
| WP4263,Pancreatic adenocarcinoma pathway,88,wikipathways
|
| WP4271,Vitamin B12 disorders,14,wikipathways
|
| WP428,Wnt signaling,114,wikipathways
|
| WP4288,MTHFR deficiency,24,wikipathways
|
| WP4290,Metabolic reprogramming in colon cancer,42,wikipathways
|
| WP4292,Methionine metabolism leading to sulfur amino acids and related disorders,13,wikipathways
|
| WP4298,Acute viral myocarditis,85,wikipathways
|
| WP43,Oxidation by cytochrome P450,62,wikipathways
|
| WP430,Statin inhibition of cholesterol production,31,wikipathways
|
| WP4300,Extracellular vesicles in the crosstalk of cardiac cells,21,wikipathways
|
| WP4301,Inhibition of exosome biogenesis and secretion by manumycin A in CRPC cells,18,wikipathways
|
| WP4304,Oligodendrocyte specification and differentiation leading to myelin components for CNS,31,wikipathways
|
| WP4312,Rett syndrome,48,wikipathways
|
| WP4313,Ferroptosis,66,wikipathways
|
| WP4318,Mitochondrial fission and fusion,13,wikipathways
|
| WP4320,Effect of progerin on genes involved in progeria,37,wikipathways
|
| WP4321,Thermogenesis,108,wikipathways
|
| WP4324,Mitochondrial complex I assembly model OXPHOS system,56,wikipathways
|
| WP4329,miRNA role in immune response in sepsis,64,wikipathways
|
| WP4331,Neovascularization processes,37,wikipathways
|
| WP4336,ncRNAs in Wnt signaling in hepatocellular carcinoma,89,wikipathways
|
| WP4337,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,17,wikipathways
|
| WP4341,Non genomic actions of 1 25 dihydroxyvitamin D3,76,wikipathways
|
| WP4352,Ciliary landscape,216,wikipathways
|
| WP4357,NRF2 ARE regulation,23,wikipathways
|
| WP437,EGF EGFR signaling,159,wikipathways
|
| WP438,Non homologous end joining,10,wikipathways
|
| WP4389,Bile acid synthesis and enterohepatic circulation ,12,wikipathways
|
| WP4396,Nonalcoholic fatty liver disease,154,wikipathways
|
| WP4462,Platelet mediated interactions with vascular and circulating cells,17,wikipathways
|
| WP4478,LTF danger signal response pathway,19,wikipathways
|
| WP4481,Resistin as a regulator of inflammation,33,wikipathways
|
| WP4482,Vitamin D in inflammatory diseases,22,wikipathways
|
| WP4483,Relationship between inflammation COX 2 and EGFR,25,wikipathways
|
| WP4484,Control of immune tolerance by vasoactive intestinal peptide,13,wikipathways
|
| WP4493,Cells and molecules involved in local acute inflammatory response ,17,wikipathways
|
| WP4494,Selective expression of chemokine receptors during T cell polarization,29,wikipathways
|
| WP4495,IL10 anti inflammatory signaling,12,wikipathways
|
| WP4496,Signal transduction through IL1R,33,wikipathways
|
| WP45,G1 to S cell cycle control,64,wikipathways
|
| WP4504,Cysteine and methionine catabolism,16,wikipathways
|
| WP4521,Glycosylation and related congenital defects,25,wikipathways
|
| WP4522,Metabolic pathway of LDL HDL and TG including diseases,17,wikipathways
|
| WP4523,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism,16,wikipathways
|
| WP4524,Alternative pathway of fetal androgen synthesis,11,wikipathways
|
| WP453,Inflammatory response pathway,30,wikipathways
|
| WP4532,Intraflagellar transport proteins binding to dynein,27,wikipathways
|
| WP4533,Transcription co factors SKI and SKIL protein partners,18,wikipathways
|
| WP4534,Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms,47,wikipathways
|
| WP4535,Envelope proteins and their potential roles in EDMD physiopathology,46,wikipathways
|
| WP4536,Genes related to primary cilium development based on CRISPR ,104,wikipathways
|
| WP4537,Hippo YAP signaling,22,wikipathways
|
| WP4538,Regulatory circuits of STAT3 signaling,78,wikipathways
|
| WP4539,Synaptic signaling associated with autism spectrum disorder,51,wikipathways
|
| WP4540,Hippo signaling regulation,98,wikipathways
|
| WP4541,Hippo Merlin signaling dysregulation,121,wikipathways
|
| WP4542,Leukocyte intrinsic Hippo pathway functions,35,wikipathways
|
| WP4545,Oxysterols derived from cholesterol,51,wikipathways
|
| WP4549,Fragile X syndrome,122,wikipathways
|
| WP455,GPCRs class A rhodopsin like,260,wikipathways
|
| WP4553,FBXL10 enhancement of MAP ERK signaling in diffuse large B cell lymphoma,33,wikipathways
|
| WP4558,Interferon mediated signaling,37,wikipathways
|
| WP4559,Interactions between immune cells and microRNAs in tumor microenvironment,47,wikipathways
|
| WP4560,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,18,wikipathways
|
| WP4564,Neural crest cell migration during development,40,wikipathways
|
| WP4565,Neural crest cell migration in cancer,43,wikipathways
|
| WP4566,Translation inhibitors in chronically activated PDGFRA cells,46,wikipathways
|
| WP4577,Neurodegeneration with brain iron accumulation NBIA subtypes pathway,44,wikipathways
|
| WP4582,Cancer immunotherapy by CTLA4 blockade,14,wikipathways
|
| WP4583,Biomarkers for urea cycle disorders,12,wikipathways
|
| WP4584,Biomarkers for pyrimidine metabolism disorders,15,wikipathways
|
| WP4585,Cancer immunotherapy by PD 1 blockade,23,wikipathways
|
| WP4589,Major receptors targeted by epinephrine and norepinephrine,16,wikipathways
|
| WP4595,Urea cycle and associated pathways,24,wikipathways
|
| WP4628,Aerobic glycolysis augmented,13,wikipathways
|
| WP4630,Measles virus infection,136,wikipathways
|
| WP465,Tryptophan metabolism,33,wikipathways
|
| WP4655,Cytosolic DNA sensing pathway,74,wikipathways
|
| WP4656,Joubert syndrome,76,wikipathways
|
| WP4657,22q11 2 copy number variation syndrome,124,wikipathways
|
| WP4658,Small cell lung cancer,95,wikipathways
|
| WP4659,Gastrin signaling,115,wikipathways
|
| WP466,DNA replication,42,wikipathways
|
| WP4666,Hepatitis B infection,152,wikipathways
|
| WP4673,Male infertility,144,wikipathways
|
| WP4674,Head and neck squamous cell carcinoma,74,wikipathways
|
| WP4685,Melanoma,70,wikipathways
|
| WP4686,Leucine isoleucine and valine metabolism,24,wikipathways
|
| WP4698,Vitamin D sensitive calcium signaling in depression,37,wikipathways
|
| WP47,Hedgehog signaling,16,wikipathways
|
| WP4705,Pathways of nucleic acid metabolism and innate immune sensing,16,wikipathways
|
| WP4707,Aspirin and miRNAs,10,wikipathways
|
| WP4718,Cholesterol metabolism with Bloch and Kandutsch Russell pathways,47,wikipathways
|
| WP4719,Eicosanoid metabolism via cyclooxygenases COX ,31,wikipathways
|
| WP4721,Eicosanoid metabolism via lipooxygenases LOX ,29,wikipathways
|
| WP4722,Glycerolipids and glycerophospholipids,22,wikipathways
|
| WP4723,Omega 3 omega 6 fatty acid synthesis,15,wikipathways
|
| WP4724,Omega 9 fatty acid synthesis,14,wikipathways
|
| WP4725,Sphingolipid metabolism overview,27,wikipathways
|
| WP4726,Sphingolipid metabolism integrated pathway,26,wikipathways
|
| WP474,Endochondral ossification,63,wikipathways
|
| WP4746,Thyroid hormones production and peripheral downstream signaling effects,92,wikipathways
|
| WP4747,Netrin UNC5B signaling,52,wikipathways
|
| WP4752,Base excision repair,43,wikipathways
|
| WP4753,Nucleotide excision repair,44,wikipathways
|
| WP4754,IL18 signaling,56,wikipathways
|
| WP4756,Renin angiotensin aldosterone system RAAS ,44,wikipathways
|
| WP4758,Nephrotic syndrome,45,wikipathways
|
| WP4760,PKC gamma calcium signaling in ataxia,22,wikipathways
|
| WP4767,FGFR3 signaling in chondrocyte proliferation and terminal differentiation,27,wikipathways
|
| WP477,Cytoplasmic ribosomal proteins,88,wikipathways
|
| WP4784,Proteoglycan biosynthesis,18,wikipathways
|
| WP4786,Type I collagen synthesis in the context of osteogenesis imperfecta,33,wikipathways
|
| WP4787,Osteoblast differentiation and related diseases,119,wikipathways
|
| WP4788,Autosomal recessive osteopetrosis pathways,11,wikipathways
|
| WP4790,FGF23 signaling in hypophosphatemic rickets and related disorders,23,wikipathways
|
| WP4792,Purine metabolism,13,wikipathways
|
| WP4803,Ciliopathies,184,wikipathways
|
| WP4806,EGFR tyrosine kinase inhibitor resistance,84,wikipathways
|
| WP4808,Endochondral ossification with skeletal dysplasias,63,wikipathways
|
| WP481,Insulin signaling,160,wikipathways
|
| WP4814,Somatic sex determination,16,wikipathways
|
| WP4815,Glycosaminoglycan degradation,17,wikipathways
|
| WP4816,TGF beta receptor signaling in skeletal dysplasias,59,wikipathways
|
| WP4823,Genes controlling nephrogenesis,46,wikipathways
|
| WP4829,mBDNF and proBDNF regulation of GABA neurotransmission,38,wikipathways
|
| WP4830,GDNF RET signaling axis,31,wikipathways
|
| WP4838,Regucalcin in proximal tubule epithelial kidney cells,32,wikipathways
|
| WP4842,Mammalian disorder of sexual development,25,wikipathways
|
| WP4844,Influence of laminopathies on Wnt signaling,37,wikipathways
|
| WP4846,SARS CoV 2 and COVID 19 pathway,11,wikipathways
|
| WP4856,Intracellular trafficking proteins involved in CMT neuropathy,27,wikipathways
|
| WP4861,Endoplasmic reticulum stress response in coronavirus infection,46,wikipathways
|
| WP4863,Host pathogen interaction of human coronaviruses autophagy,19,wikipathways
|
| WP4864,Host pathogen interaction of human coronaviruses apoptosis,22,wikipathways
|
| WP4868,Type I interferon induction and signaling during SARS CoV 2 infection,32,wikipathways
|
| WP4871,Kisspeptin kisspeptin receptor system in the ovary,39,wikipathways
|
| WP4872,MAP3K1 role in promoting and blocking gonadal determination,17,wikipathways
|
| WP4874,CAMKK2 pathway,110,wikipathways
|
| WP4875,Disruption of postsynaptic signaling by CNV,33,wikipathways
|
| WP4877,Host pathogen interaction of human coronaviruses MAPK signaling,36,wikipathways
|
| WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,57,wikipathways
|
| WP4880,Host pathogen interaction of human coronaviruses interferon induction,33,wikipathways
|
| WP4884,Pathogenesis of SARS CoV 2 mediated by nsp9 nsp10 complex,21,wikipathways
|
| WP4891,COVID 19 adverse outcome pathway,16,wikipathways
|
| WP49,IL2 signaling,37,wikipathways
|
| WP4900,Purinergic signaling,34,wikipathways
|
| WP4905,1q21 1 copy number variation syndrome,27,wikipathways
|
| WP4906,3q29 copy number variation syndrome,64,wikipathways
|
| WP4912,SARS coronavirus and innate immunity,31,wikipathways
|
| WP4917,Proximal tubule transport,57,wikipathways
|
| WP4919,Neuroinflammation,13,wikipathways
|
| WP4921,Mitochondrial complex III assembly,16,wikipathways
|
| WP4922,Mitochondrial complex IV assembly,34,wikipathways
|
| WP4923,Autophagy,30,wikipathways
|
| WP4925,Unfolded protein response,23,wikipathways
|
| WP4928,MAPK pathway in congenital thyroid cancer,16,wikipathways
|
| WP4932,7q11 23 copy number variation syndrome,107,wikipathways
|
| WP4936,Perturbations to host cell autophagy induced by SARS CoV 2 proteins,44,wikipathways
|
| WP4941,GPR143 in melanocytes and retinal pigment epithelium cells,30,wikipathways
|
| WP4942,15q13 3 copy number variation syndrome,20,wikipathways
|
| WP4946,DNA repair pathways full network,121,wikipathways
|
| WP4947,Nitric oxide metabolism in cystic fibrosis,13,wikipathways
|
| WP4949,16p11 2 proximal deletion syndrome,76,wikipathways
|
| WP4950,16p11 2 distal deletion syndrome,33,wikipathways
|
| WP496,Steroid biosynthesis,10,wikipathways
|
| WP4961,STING pathway in Kawasaki like disease and COVID 19,21,wikipathways
|
| WP4962,Airway smooth muscle cell contraction,16,wikipathways
|
| WP4963,p53 transcriptional gene network,97,wikipathways
|
| WP4969,Renin Angiotensin System and Bradykinin pathways in COVID 19,29,wikipathways
|
| WP497,Urea cycle and metabolism of amino groups,21,wikipathways
|
| WP4970,Galanin receptor pathway,16,wikipathways
|
| WP4971,Phosphoinositides metabolism,49,wikipathways
|
| WP500,Glycogen synthesis and degradation,40,wikipathways
|
| WP501,GPCRs class C metabotropic glutamate pheromone,15,wikipathways
|
| WP5027,nsp1 from SARS CoV 2 inhibits translation initiation in the host cell,18,wikipathways
|
| WP5028,Glycine metabolism including IMDs,15,wikipathways
|
| WP5033,Genes associated with the development of rheumatoid arthritis,18,wikipathways
|
| WP5036,Angiotensin II receptor type 1 pathway,28,wikipathways
|
| WP5037,Riboflavin and CoQ disorders,14,wikipathways
|
| WP5038,Mitochondrial immune response to SARS CoV 2,34,wikipathways
|
| WP5039,SARS CoV 2 innate immunity evasion and cell specific immune response,66,wikipathways
|
| WP5044,Kynurenine pathway and links to cell senescence,24,wikipathways
|
| WP5046,NAD metabolism in oncogene induced senescence and mitochondrial dysfunction associated senescence,22,wikipathways
|
| WP5049,Glycolysis in senescence,11,wikipathways
|
| WP5050,TCA cycle in senescence,10,wikipathways
|
| WP5052,Nephrogenesis,18,wikipathways
|
| WP5053,Development of ureteric derived collecting system,48,wikipathways
|
| WP5055,Burn wound healing,75,wikipathways
|
| WP5061,Fatty acid transporters,18,wikipathways
|
| WP5063,FOXP3 in COVID 19,15,wikipathways
|
| WP5064,7 oxo C and 7 beta HC pathways,27,wikipathways
|
| WP5066,FOXA2 pathway,21,wikipathways
|
| WP5072,Modulators of TCR signaling and T cell activation,61,wikipathways
|
| WP5074,Kallmann syndrome,24,wikipathways
|
| WP5078,T cell modulation and desmoplasia in pancreatic cancer,55,wikipathways
|
| WP5083,Neuroinflammation and glutamatergic signaling,140,wikipathways
|
| WP5085,Vasopressin regulated water reabsorption,44,wikipathways
|
| WP5087,Pleural mesothelioma,439,wikipathways
|
| WP5088,Prostaglandin signaling,33,wikipathways
|
| WP5090,Complement system in neuronal development and plasticity,107,wikipathways
|
| WP5092,Interactions of natural killer cells in pancreatic cancer,28,wikipathways
|
| WP5094,Orexin receptor pathway,88,wikipathways
|
| WP5095,Overview of proinflammatory and profibrotic mediators,129,wikipathways
|
| WP5098,T cell activation SARS CoV 2,88,wikipathways
|
| WP51,Regulation of actin cytoskeleton,150,wikipathways
|
| WP5101,Congenital generalized lipodystrophy,18,wikipathways
|
| WP5102,Familial partial lipodystrophy,30,wikipathways
|
| WP5103,Progeria associated lipodystrophy,22,wikipathways
|
| WP5104,Acquired partial lipodystrophy Barraquer Simons syndrome,10,wikipathways
|
| WP5108,Familial hyperlipidemia type 1,18,wikipathways
|
| WP5109,Familial hyperlipidemia type 2,16,wikipathways
|
| WP5110,Familial hyperlipidemia type 3,13,wikipathways
|
| WP5111,Familial hyperlipidemia type 4,22,wikipathways
|
| WP5112,Familial hyperlipidemia type 5,15,wikipathways
|
| WP5113,Antiviral and anti inflammatory effects of Nrf2 on SARS CoV 2 pathway,32,wikipathways
|
| WP5114,Nucleotide excision repair in xeroderma pigmentosum ,75,wikipathways
|
| WP5115,Network map of SARS CoV 2 signaling,254,wikipathways
|
| WP5117,Cohesin complex Cornelia de Lange syndrome,34,wikipathways
|
| WP5118,SMC1 SMC3 role in DNA damage Cornelia de Lange Syndrome,11,wikipathways
|
| WP5120,Inclusion body myositis,11,wikipathways
|
| WP5121,Sphingolipid metabolism in senescence,28,wikipathways
|
| WP5122,Prostaglandin and leukotriene metabolism in senescence ,33,wikipathways
|
| WP5123,Mitochondrial fatty acid oxidation disorders,19,wikipathways
|
| WP5124,Alzheimer 39 s disease,264,wikipathways
|
| WP5130,Th17 cell differentiation pathway,70,wikipathways
|
| WP5142,Calcium mediated T cell apoptosis involved in inclusion body myositis,20,wikipathways
|
| WP5144,NRP1 triggered signaling in pancreatic cancer ,53,wikipathways
|
| WP5145,COVID 19 structural coverage map,26,wikipathways
|
| WP5146,Lung pathology of COVID 19,20,wikipathways
|
| WP5148,Complement mediated inflammation of pulmonary alveolus in COVID 19 hypothetical pathway ,12,wikipathways
|
| WP5149,Lipid metabolism in senescent cells,20,wikipathways
|
| WP5150,Spina bifida,12,wikipathways
|
| WP5152,Iron sulfur cluster biogenesis,15,wikipathways
|
| WP5153,N glycan biosynthesis,57,wikipathways
|
| WP5158,Urotensin II mediated signaling,69,wikipathways
|
| WP516,Exercise and hypertrophy in skeletal muscle,20,wikipathways
|
| WP5166,Glyoxylate metabolism,11,wikipathways
|
| WP5171,Leukotriene metabolic pathway,13,wikipathways
|
| WP5172,Iron metabolism disorders,17,wikipathways
|
| WP5173,Disorders of galactose metabolism ,13,wikipathways
|
| WP5174,Ulcerative colitis signaling,18,wikipathways
|
| WP5176,Disorders of bile acid synthesis and biliary transport,29,wikipathways
|
| WP5178,Disorders of fructose metabolism,14,wikipathways
|
| WP5180,DYRK1A involvement regarding cell proliferation in brain development,62,wikipathways
|
| WP5181,Roles of ceramides in development of insulin resistance,23,wikipathways
|
| WP5182,Pro survival signaling of neuroprotectin D1,15,wikipathways
|
| WP5183,SARS CoV 2 mitochondrial chronic oxidative stress and endothelial dysfunction,26,wikipathways
|
| WP5186,Vitamin K metabolism and activation of dependent proteins,13,wikipathways
|
| WP5187,mRNA vaccine activation of dendritic cell and induction of IFN 1,10,wikipathways
|
| WP5188,Retinol metabolism,17,wikipathways
|
| WP5191,Resolvin E1 and resolvin D1 signaling decrease inflammation,12,wikipathways
|
| WP5192,Modulation of PI3K Akt mTOR signaling by bioactive sphingolipids,14,wikipathways
|
| WP5193,Cholesterol synthesis disorders,18,wikipathways
|
| WP5194,Synthesis of ceramides and 1 deoxyceramides,22,wikipathways
|
| WP5198,Inflammatory bowel disease signaling,43,wikipathways
|
| WP5199,PtdIns 4 5 P2 in cytokinesis pathway,12,wikipathways
|
| WP5200,Dravet syndrome,29,wikipathways
|
| WP5202,Alstrom syndrome,34,wikipathways
|
| WP5205,Clock controlled autophagy in bone metabolism,80,wikipathways
|
| WP5215,Targeted agents in triple negative breast cancer,38,wikipathways
|
| WP5216,Warburg effect modulated by deubiquitinating enzymes and their substrates,26,wikipathways
|
| WP5218,Extrafollicular and follicular B cell activation by SARS CoV 2,76,wikipathways
|
| WP5220,Metabolic reprogramming in pancreatic cancer,42,wikipathways
|
| WP5221,2q11 2 copy number variation syndrome,33,wikipathways
|
| WP5222,2q13 copy number variation syndrome,63,wikipathways
|
| WP5223,2q21 1 copy number variation syndrome,18,wikipathways
|
| WP5224,2q37 copy number variation syndrome,143,wikipathways
|
| WP5231,Hippocampal synaptogenesis and neurogenesis,27,wikipathways
|
| WP5233,Arsenic metabolism and reactive oxygen species generation,10,wikipathways
|
| WP5234,Bardet Biedl syndrome,88,wikipathways
|
| WP5236,Markers of kidney cell lineage,58,wikipathways
|
| WP5238,Cholestasis,19,wikipathways
|
| WP524,G13 signaling,38,wikipathways
|
| WP5265,Neurogenesis regulation in the olfactory epithelium,57,wikipathways
|
| WP5269,Genetic causes of porto sinusoidal vascular disease,37,wikipathways
|
| WP5272,LDL influence on CD14 and TLR4,23,wikipathways
|
| WP5275,Ether lipid biosynthesis,22,wikipathways
|
| WP5276,Estrogen synthesis and metabolism,24,wikipathways
|
| WP5279,Mineralocorticoid biosynthesis,14,wikipathways
|
| WP5280,Glucocorticoid biosynthesis,14,wikipathways
|
| WP5283,Chronic hyperglycemia impairment of neuron function,46,wikipathways
|
| WP5284,Cell interactions in pancreatic cancer microenvironment,27,wikipathways
|
| WP5285,Immune infiltration in pancreatic cancer,39,wikipathways
|
| WP5287,17q12 copy number variation syndrome,101,wikipathways
|
| WP5289,Axon guidance,72,wikipathways
|
| WP5292,Glycosphingolipid metabolism,21,wikipathways
|
| WP5293,Acute myeloid leukemia,69,wikipathways
|
| WP5294,Sildenafil treatment,22,wikipathways
|
| WP5299,Ganglio series sphingolipid metabolism,13,wikipathways
|
| WP53,ID signaling,16,wikipathways
|
| WP530,Cytokines and inflammatory response,26,wikipathways
|
| WP5300,TROP2 regulatory signaling,45,wikipathways
|
| WP5302,Neolacto series sphingolipid metabolism,11,wikipathways
|
| WP5304,Cholesterol metabolism,72,wikipathways
|
| WP531,DNA mismatch repair,23,wikipathways
|
| WP5312,Metabolic pathways of fibroblasts,32,wikipathways
|
| WP5314,Lactate shuttle in glial cells,13,wikipathways
|
| WP5318,Female steroid hormones in cardiomyocyte energy metabolism,14,wikipathways
|
| WP5320,Male steroid hormones in cardiomyocyte energy metabolism,13,wikipathways
|
| WP5323,Fatty acid and lipoprotein transport in hepatocytes,35,wikipathways
|
| WP5324,Octadecanoid formation from linoleic acid,13,wikipathways
|
| WP5329,Cholesterol biosynthesis pathway in hepatocytes,43,wikipathways
|
| WP5331,Autophagy in pancreatic ductal adenocarcinoma,20,wikipathways
|
| WP5333,Enterocyte cholesterol metabolism,36,wikipathways
|
| WP5336,Induction of autophagy and toll like receptor signaling by graphene oxide ,11,wikipathways
|
| WP534,Glycolysis and gluconeogenesis,45,wikipathways
|
| WP5342,Pathophysiological roles of DUX4 in FSHD1,32,wikipathways
|
| WP5344,Cardiomyocyte signaling converging on titin,33,wikipathways
|
| WP5345,1p36 copy number variation syndrome,103,wikipathways
|
| WP5346,8p23 1 copy number variation syndrome,55,wikipathways
|
| WP5347,IL26 signaling,48,wikipathways
|
| WP5348,11p11 2 copy number variation syndrome ,56,wikipathways
|
| WP5351,Kleefstra syndrome,29,wikipathways
|
| WP5352,10q11 21q11 23 copy number variation syndrome,61,wikipathways
|
| WP5353,Macrophage stimulating protein MSP signaling,108,wikipathways
|
| WP5355,Metabolic epileptic disorders,92,wikipathways
|
| WP5356,Affected pathways in Duchenne muscular dystrophy,75,wikipathways
|
| WP5358,JAK STAT signaling in the regulation of beta cells,34,wikipathways
|
| WP536,Calcium regulation in cardiac cells,152,wikipathways
|
| WP5360,KCNQ2 related epilepsies,19,wikipathways
|
| WP5362,TAR syndrome,63,wikipathways
|
| WP5365,4p16 3 copy number variation,32,wikipathways
|
| WP5366,NF1 copy number variation syndrome ,109,wikipathways
|
| WP5367,Rubinstein Taybi syndrome 1,15,wikipathways
|
| WP5368,Sulfatase and aromatase pathway,14,wikipathways
|
| WP5372,Involvement of secretase in neurodegenerative diseases,17,wikipathways
|
| WP5373,Osteoarthritic chondrocyte hypertrophy,50,wikipathways
|
| WP5376,17p13 3 YWHAE copy number variation,21,wikipathways
|
| WP5380,5q35 copy number variation,111,wikipathways
|
| WP5381,Smith Magenis and Potocki Lupski syndrome copy number variation,159,wikipathways
|
| WP5382,TGFB Smad signaling,12,wikipathways
|
| WP5385,Growth factors and hormones in beta cell proliferation,26,wikipathways
|
| WP5390,Pancreatic cancer subtypes,50,wikipathways
|
| WP5393,Androgen biosynthesis,21,wikipathways
|
| WP5394,UDP derived sugars synthesis in fibroblasts,11,wikipathways
|
| WP5395,Glycosaminoglycan synthesis in fibroblasts,41,wikipathways
|
| WP5396,Enterohepatic circulation of bile acids,12,wikipathways
|
| WP5398,NRXN1 deletion syndrome,17,wikipathways
|
| WP5399,NPHP1 deletion syndrome,11,wikipathways
|
| WP5400,6q16 copy number variation,14,wikipathways
|
| WP5401,7q11 23 distal copy number variation,22,wikipathways
|
| WP5402,10q22q23 copy number variation,64,wikipathways
|
| WP5406,13q12 12 copy number variation,34,wikipathways
|
| WP5407,15q11q13 copy number variation,59,wikipathways
|
| WP5408,15q25 copy number variation,46,wikipathways
|
| WP5409,PAFAH1B1 copy number variation,11,wikipathways
|
| WP5411,Phosphatidyl inositol phosphate pathway,46,wikipathways
|
| WP5412,8q11 23 RB1CC1 copy number variation,16,wikipathways
|
| WP5414,IDO metabolic pathway,11,wikipathways
|
| WP5417,Cell lineage map for neuronal differentiation,132,wikipathways
|
| WP5422,IL19 signaling,28,wikipathways
|
| WP5424,Omega 6 fatty acids in senescence,48,wikipathways
|
| WP5426,HDAC6 interactions in the central nervous system,112,wikipathways
|
| WP5432,Omega 3 fatty acids in senescence,31,wikipathways
|
| WP5433,PGK1 PKM2 KHKC KHKA acting as protein kinases,15,wikipathways
|
| WP5434,Cancer pathways,509,wikipathways
|
| WP5437,GNAQ pathways in port wine stain,21,wikipathways
|
| WP5443,Effects of MFN2 mutation,24,wikipathways
|
| WP545,Complement activation,23,wikipathways
|
| WP5461,Primary ovarian insufficiency,137,wikipathways
|
| WP5465,Fanconi anemia,48,wikipathways
|
| WP5469,Hallmark of cancer metastasis and epithelial to mesenchymal transition,23,wikipathways
|
| WP5470,Effect of omega 3 PUFA on Huntington 39 s disease pathways,120,wikipathways
|
| WP5472,Phosphoinositide 3 kinase PI3K family,13,wikipathways
|
| WP5473,Cytokine cytokine receptor interaction,258,wikipathways
|
| WP5474,Catabolism of skeletal muscle in cachexia,40,wikipathways
|
| WP5475,Hallmark of cancer sustaining proliferative signaling,98,wikipathways
|
| WP5477,Molecular pathway for oxidative stress,49,wikipathways
|
| WP5483,Hallmark of cancer non mutational epigenetic reprogramming,17,wikipathways
|
| WP5485,Post COVID neuroinflammation,24,wikipathways
|
| WP5489,Regulation of cytotoxic T cell responses by Malat1 miR 15 16 circuit ,12,wikipathways
|
| WP5490,Inhibition of GNAQ regulated signaling in uveal melanoma,33,wikipathways
|
| WP5491,Transcriptional regulation of memory B cell differentiation,48,wikipathways
|
| WP5492,AMPK regulation of mammary milk protein synthesis,20,wikipathways
|
| WP5493,Effect of dasatinib on the BCR ABL signaling pathway,45,wikipathways
|
| WP5494,Tyrosine kinase inhibitors in glioblastoma,26,wikipathways
|
| WP5495,Targeting YAP in pancreatic ductal adenocarcinoma PDAC ,26,wikipathways
|
| WP5496,Targeted therapy in breast cancer,26,wikipathways
|
| WP5497,Cyclin dependent kinase 4 6 inhibitors in breast cancer,38,wikipathways
|
| WP550,Biogenic amine synthesis,15,wikipathways
|
| WP5500,Bempedoic acid therapy in atherosclerosis and metabolic syndrome,26,wikipathways
|
| WP5501,GNAQ p R183Q drives capillary malformation,25,wikipathways
|
| WP5502,16p13 11 copy number variation syndrome ,29,wikipathways
|
| WP5503,Albuterol and budesonide therapy for asthma,26,wikipathways
|
| WP5504,Disorders of mitochondrial homeostatis dynamics protein import and quality control,63,wikipathways
|
| WP5505,Glycosylphosphatidyl inositol anchor pathway,26,wikipathways
|
| WP5510,16p12 2 copy number variation syndrome 520kb ,54,wikipathways
|
| WP5512,Vedolizumab therapy for inflammatory bowel disease,10,wikipathways
|
| WP5514,DNAJB1 PRKACA fusion in fibrolamellar liver cancer,11,wikipathways
|
| WP5516,IL23 inhibitors in inflammatory bowel disease,18,wikipathways
|
| WP5521,SLC25A46 pathway,21,wikipathways
|
| WP5523,HINT1 pathway,25,wikipathways
|
| WP5524,HSPB3 in Charcot Marie Tooth disease,15,wikipathways
|
| WP5526,Age related macular degeneration,17,wikipathways
|
| WP5527,NF kB signaling and ARTD family members,28,wikipathways
|
| WP5528,JAK STAT signaling and ARTD family members,14,wikipathways
|
| WP5529,Wnt Beta catenin signaling and ARTD family members,15,wikipathways
|
| WP5530,MAPK signaling and ARTD family members,32,wikipathways
|
| WP5531,AKT signaling and ARTD family members,34,wikipathways
|
| WP5534,Visual cycle,15,wikipathways
|
| WP5536,Wnt signaling in adult hippocampal neurogenesis,12,wikipathways
|
| WP5537,Psoriasis mechanism and therapies,18,wikipathways
|
| WP5538,Atopic dermatitis mechanism and therapies,23,wikipathways
|
| WP554,ACE inhibitor pathway,17,wikipathways
|
| WP5541,BDNF signaling in neurodevelopment,119,wikipathways
|
| WP5545,Fibrotic response of trabecular meshwork cells to TGFB3 and ENPP2 in aqueous humor,15,wikipathways
|
| WP5546,22q11 2 distal CNV,139,wikipathways
|
| WP5548,Blood based neuroinflammation markers ,22,wikipathways
|
| WP5549,Tryptophan kynurenine pathway in post COVID syndrome,18,wikipathways
|
| WP5557,ANK2 pathway in epilepsy development,24,wikipathways
|
| WP5559,Lupus pathogenesis,19,wikipathways
|
| WP5560,Lupus therapies,30,wikipathways
|
| WP5561,Integrative Analysis of Treg Glial Interactions ,112,wikipathways
|
| WP5562,Celiac disease mechanism and therapies,13,wikipathways
|
| WP5563,RNA polymerase II transcription the preinitiation complex,69,wikipathways
|
| WP5564,FACT complex and DNA double strand break repair,31,wikipathways
|
| WP5565,Transcription activation RNA polymerase I and KAT2A B and inhibition NuRD complex ,81,wikipathways
|
| WP5566,SHANK3 pathway involved in Phelan McDermid syndrome,34,wikipathways
|
| WP5567,Telomere end packaging and neurodevelopmental disorders,48,wikipathways
|
| WP5568,SOX genes and their influence on neurogenesis and neurodevelopmental disorders,28,wikipathways
|
| WP5569,Uterine natural killer cells and progesterone estrogen and chorionic gonadotropin,53,wikipathways
|
| WP5570,Glycerol metabolism including linked IMDs,29,wikipathways
|
| WP5571,Deregulating cellular metabolism through non genotoxic carcinogens,22,wikipathways
|
| WP5572,Nucleosome remodeling complex,33,wikipathways
|
| WP5573,Tessadori Bicknell van Haaften syndrome variants nucleosome assembly,22,wikipathways
|
| WP5574,Oligodendrocyte development,48,wikipathways
|
| WP5576,Killer cell immunoglobulin like receptors and human leukocyte antigen C pathway,22,wikipathways
|
| WP558,Complement and coagulation cascades,58,wikipathways
|
| WP5580,HLA C allotypes interactions with KIR on dNK cells,22,wikipathways
|
| WP5584,Signaling lipids,27,wikipathways
|
| WP5598,Sodium channel in epilepsy,38,wikipathways
|
| WP5599,KCNQ2 and KCNQ3 related epilepsy,31,wikipathways
|
| WP560,TGF beta receptor signaling,55,wikipathways
|
| WP5600,GABA and glutamate signalling in epileptogenesis,123,wikipathways
|
| WP5601,Caffeine in blood vessels,33,wikipathways
|
| WP5603,Caffeine in myocytes,36,wikipathways
|
| WP5605,Hemoglobin switching embryonic fetal and adult,12,wikipathways
|
| WP5606,Beta globin gene expression regulation,24,wikipathways
|
| WP5607,Erythropoiesis,25,wikipathways
|
| WP5609,Inhibitors of metabolism in melanoma therapy,36,wikipathways
|
| WP58,Monoamine GPCRs,33,wikipathways
|
| WP581,EPO receptor signaling,26,wikipathways
|
| WP585,Interferon type I signaling,54,wikipathways
|
| WP61,Notch signaling,54,wikipathways
|
| WP615,Senescence and autophagy in cancer,105,wikipathways
|
| WP619,Type II interferon signaling,37,wikipathways
|
| WP623,Oxidative phosphorylation,60,wikipathways
|
| WP673,ErbB signaling,90,wikipathways
|
| WP69,T cell receptor signaling,75,wikipathways
|
| WP691,Tamoxifen metabolism,21,wikipathways
|
| WP692,Sulfation biotransformation reaction,18,wikipathways
|
| WP697,Estrogen metabolism,18,wikipathways
|
| WP698,Glucuronidation,26,wikipathways
|
| WP702,Metapathway biotransformation Phase I and II,184,wikipathways
|
| WP706,Sudden infant death syndrome SIDS susceptibility pathways,160,wikipathways
|
| WP707,DNA damage response,69,wikipathways
|
| WP710,DNA damage response only ATM dependent ,110,wikipathways
|
| WP712,Estrogen signaling,23,wikipathways
|
| WP716,Vitamin A and carotenoid metabolism,43,wikipathways
|
| WP722,Serotonin HTR1 group and FOS pathway,37,wikipathways
|
| WP727,Monoamine transport and regulation,32,wikipathways
|
| WP732,Serotonin receptor 2 and ELK SRF GATA4 signaling,20,wikipathways
|
| WP734,Serotonin receptor 4 6 7 and NR3C signaling,19,wikipathways
|
| WP75,Toll like receptor signaling,95,wikipathways
|
| WP78,TCA cycle aka Krebs or citric acid cycle ,18,wikipathways
|
| WP80,Nucleotide GPCRs,11,wikipathways
|
| WP98,Prostaglandin synthesis and regulation,46,wikipathways
|
|
|
